Imagine a world where the smallest, most overlooked components of human cells hold the key to combating some of the most pressing health crises, such as obesity and aging. Mitochondrial microproteins, tiny yet powerful regulators within cells, are emerging as a groundbreaking focus in biomedical
What happens when the joy of expecting a child is overshadowed by the shadow of life-threatening heart conditions? For countless women with cardiovascular disease, this is not a hypothetical question but a harsh reality that they face every day. Across the globe, maternal heart disease stands as
Imagine a patient recovering from a provoked venous thromboembolism (VTE), such as deep vein thrombosis (DVT) triggered by surgery, only to face an ongoing risk of recurrence due to chronic conditions like obesity or inflammatory disorders. With recurrence rates posing a significant threat to
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research and development, coupled with a deep understanding of technology and innovation in the industry, has positioned him as a leading voice in cancer research. Today, we’ll dive into his
In the fast-paced realm of healthcare innovation, a remarkable partnership between Singapore-based Nanyang Biologics (NYB), global digital infrastructure giant Equinix, and technology leader Hewlett Packard Enterprise (HPE) is capturing attention across the industry. This collaboration has given
In a landscape where medical research often progresses at a cautious pace, the Queen Elizabeth Hospital (QEH) has emerged as a trailblazer, setting a remarkable benchmark in the United Kingdom by achieving the extraordinary feat of becoming the fastest site in the UK to recruit 100 participants for
